Home > Resources > Company Profiles > Covidien Limited

Covidien Limited (COV)

Your Name

Your Email Address *
Send a copy to me

Recipient's Email Address *

Separate multiple email addresses (max 20) with commas.

Subject *

Message

0/1500

Enter the text you see in the image *

Letters are not case-sensitive, disregard spaces.

Try a New One

This helps us prevent automated registrations and spamming.

Email Confirmation

Richard J. Meelia , CEO/Director/President

www.covidien.com

Industry: Healthcare

OPEN

LAST

PREV CLOSE

CHANGE

VOLUME

Overview

News

People

Financials

Overview

The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings.

Portfolio Articles

Have a Seat
Ever since Enron's downfall and the introduction of Sarbanes-Oxley, corporate boards have taken on a less clubby air -- presenting opportunities for first-timers.

May 02 2008

See more news on this company

News Feeds

Opening Glance: Health Care equipment and supplies AP
Jul 09 2008
Closing Glance: Health Care equipment and supplies AP
Jul 08 2008
Sector Snap: Medical Device Makers AP
Jun 23 2008

Press Releases

Covidien Celebrates its First Anniversary as an Independent Healthcare Products Company Jul-08-2008, 08:30AM EDT
Covidien Appoints New Research & Development Executives in Its Pharmaceutical and Imaging Businesses Jun-30-2008, 09:00AM EDT
Covidien Announces Latest Advance in ''Unite to Treat Sleep Apnea'' Initiative Jun-19-2008, 09:00AM EDT
Covidien Unveils Educational Bariatric Website www.bariatrics4diabetes.com Jun-16-2008, 09:00AM EDT
Covidien Launches Sandman Info(TM) and Sandman Auto(TM) CPAP Devices in the United States Jun-05-2008, 08:00AM EDT

News From Around the Web

News

Opening Glance: Health Care equipment and supplies (Boston Globe)

Jul 09 2008
Raymond James Starts Covidien (COV) at Outperform (StreetInsider)

Jul 09 2008
Covidien Ltd. to Report Third-Quarter Results on August 5, 2008 (Genetic Engineering News)

Jul 09 2008
Shares of health care equipment and supply companies mostly rise as oil prices fall (Canadian Business Online)

Jul 08 2008
Instantis Achieves Record Second-Quarter and First-Half Revenue (TMCnet.com)

Jul 08 2008
Covidien Celebrates its First Anniversary as an Independent Healthcare Products Company (PharmaLive)

Jul 08 2008
Closing Glance: Health Care equipment and supplies (Businessweek)

Jul 07 2008
Life Sciences 25 (Boston Globe)

Jul 07 2008

Employees

Number of Employees: 43,800

Revenue per Employee: $232,192

Top Executives

Timothy R. Wright, President, Divisional/Senior VP

Jose E. Almeida, Senior VP/President, Divisional

Richard G. Brown, Jr., Chief Accounting Officer/Vice President/Controller

Karen A. Quinn-Quintin, Senior VP, Divisional

Amy A. McBride-Wendell, Senior VP, Divisional

Coleman N. Lannum, Vice President, Divisional

Eric A. Kraus, Senior VP, Divisional

Board of Directors

Kevin G. DaSilva, Director/Vice President/Treasurer

Craig Arnold, Director

Joseph A. Zaccagnino, Director

Dennis H. Reilley, Chairman of the Board/Director

Timothy M. Donahue, Director

Robert H. Brust, Director

Kathy J. Herbert, Director

Randall J. Hogan, III, Director

Eric C. Green, Vice President/Other Executive Officer

Christopher J. Coughlin, Director

John H. Masterson, Director/General Counsel/Senior VP

John M. Connors, Jr., Director

Charles J. Dockendorff, Executive VP/CFO/Director

Dr. Tadataka Yamada, Director

Financials

Quarterly

Annual

Income Statement	05/2008	02/2008	12/2007	08/2007
Sales	1.06 Bil.	1.08 Bil.	1.22 Bil.	1.25 Bil.
Gross Operating Profit	1.37 Bil.	1.24 Bil.	1.39 Bil.	1.33 Bil.
Operating Income before D & A (EBITDA)	596 Mil.	472 Mil.	612 Mil.	602 Mil.
Total Income Before Interest Expenses (EBIT)	416 Mil.	647 Mil.	179 Mil.	-877 Mil.
Total Net Income	235 Mil.	470 Mil.	34 Mil.	-1.11 Bil.
Basic EPS, Total	0.47	0.94	0.07	-2.23
Diluted EPS, Total	0.46	0.94	0.07	-2.23

BALANCE STATEMENT	05/2008	02/2008	12/2007	08/2007
Cash and Equivalents	849 Mil.	NA	872 Mil.	676 Mil.
Total Assets	5.37 Bil.	NA	7.56 Bil.	7.26 Bil.
Total Liabilities	2 Bil.	NA	5.37 Bil.	8.14 Bil.
Total Capitalization	10.99 Bil.	NA	10.31 Bil.	7.36 Bil.

Cash Flow	05/2008	02/2008	12/2007	08/2007
Net Cash From Continuing Operations	-462 Mil.	NA	2.2 Bil.	1.57 Bil.
Net Cash From Investing Activities	992 Mil.	NA	-1.71 Bil.	-1.58 Bil.
Net Cash From Financing Activities	-627 Mil.	NA	110 Mil.	425 Mil.
Net Change in Cash & Cash Equivalents	-23 Mil.	NA	630 Mil.	434 Mil.

Income Statement	2007
Sales	4.92 Bil.
Gross Operating Profit	5.25 Bil.
Operating Income before D & A (EBITDA)	2.44 Bil.
Total Income Before Interest Expenses (EBIT)	339 Mil.
Total Net Income	-332 Mil.
Basic EPS, Total	-0.67
Diluted EPS, Total	-0.67

BALANCE STATEMENT	2007
Cash and Equivalents	872 Mil.
Total Assets	7.56 Bil.
Total Liabilities	5.37 Bil.
Total Capitalization	10.31 Bil.

Cash Flow	2007
Net Cash From Continuing Operations	2.2 Bil.
Net Cash From Investing Activities	-1.71 Bil.
Net Cash From Financing Activities	110 Mil.
Net Change in Cash & Cash Equivalents	630 Mil.

Covidien Limited (COV)

Company Information

Overview

Employees

Top Executives

Board of Directors

Financials

Company Profile Change Request